Iprivask®

The approved trade name in the United States is Iprivask®. For details, please visit the Food and Drug Administration (FDA) web page, http://www.fda.gov/cder/ob/default.htm and search either by trade name or by active ingredient "Desirudin".

Desirudin was approved by the FDA in April, 2003.

For product package insert, please go to the following link, http://www.fda.gov/cder/foi/label/2003/21271_iprivask_lbl.pdf.

Iprivask will be available for sale in the United States in late 2009. Please contact Canyon Pharmaceuticals, Inc. for further specific availability information. info@canyonpharma.com or 888-434-7003.

© Canyon Pharmaceuticals, Inc. Hunt Valley, Maryland U.S.A.
This Web site and its information is intended for use by United States residents only. Countries outside the United States may have regulatory requirements, data requirements or medical practices that differ from the United States and, therefore, this information may be inappropriate for use outside the United States. Site contents are intended for informational purposes only and not intended to replace discussion with a health care provider. If you have any questions regarding this site, contact Canyon Pharmaceuticals, Inc.

Primary links

Iprivask®